Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 9Brain Neoplasms 7Carcinoma, Non-Small-Cell Lung 4Rectal Neoplasms 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Lung Neoplasms 3Head and Neck Neoplasms 3Colorectal Neoplasms 3Central Nervous System Neoplasms 3Tongue Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Lymphoma 2Glioma 2Glioblastoma 2Endometrial Neoplasms 2Colonic Neoplasms 2Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Seminoma 1Salivary Gland Neoplasms 1Recurrence 1Radiation Injuries 1Prostate Adenocarcinoma 1Prolactinoma 1

Interventions

gallium 68 PSMA-11 1fluciclovine F-18 1Radiosurgery 1Proton Therapy 1Magnetic Resonance Spectroscopy 168Ga-DKFZ-PSMA-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Prostate Adenocarcinoma × Magnetic Resonance Spectroscopy × Clear all
NCT03762759 2024-05-17

Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes

Emory University

Phase 2 Unknown
140 enrolled
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡